Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non–Small Cell Lung Cancer After Resection With Curative Intent | Zendy

Matthew P. Smeltzer | Zendy; Nicholas R. Faris | Zendy; Meredith Ray | Zendy; Raymond U. Osarogiagbon | Zendy

Open Access

Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non–Small Cell Lung Cancer After Resection With Curative Intent

Author(s) -

Matthew P. Smeltzer,

Nicholas R. Faris,

Meredith Ray,

Raymond U. Osarogiagbon

Publication year - 2017

Publication title -

jama oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 8.846

H-Index - 99

eISSN - 2374-2445

pISSN - 2374-2437

DOI - 10.1001/jamaoncol.2017.2993

Subject(s) - medicine , lung cancer , nodal , resection , oncology , cancer , surgery , radiology , pathology

Pathologic nodal stage is the most significant prognostic factor in resectable non-small cell lung cancer (NSCLC). The International Association for the Study of Lung Cancer NSCLC staging project revealed intercontinental differences in N category-stratified survival. These differences may indicate differences not only in cancer biology but also in the thoroughness of the nodal examination.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research